TY - JOUR AU - Farkona, S. AU - Diamandis, E. P. AU - Blasutig, I. M. PY - 2016 DA - 2016// TI - Cancer immunotherapy: the beginning of the end of cancer? JO - BMC Med VL - 14 UR - https://doi.org/10.1186/s12916-016-0623-5 DO - 10.1186/s12916-016-0623-5 ID - Farkona2016 ER - TY - JOUR AU - Greenman, C. AU - Stephens, P. AU - Smith, R. AU - Dalgliesh, G. L. AU - Hunter, C. AU - Bignell, G. PY - 2007 DA - 2007// TI - Patterns of somatic mutation in human cancer genomes JO - Nature VL - 446 UR - https://doi.org/10.1038/nature05610 DO - 10.1038/nature05610 ID - Greenman2007 ER - TY - JOUR AU - Vogelstein, B. AU - Kinzler, K. PY - 2004 DA - 2004// TI - Cancer genes and the pathways they control JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1087 DO - 10.1038/nm1087 ID - Vogelstein2004 ER - TY - JOUR AU - Pleasance, E. D. AU - Cheetham, R. K. AU - Stephens, P. J. AU - McBride, D. J. AU - Humphray, S. J. AU - Greenman, C. D. PY - 2010 DA - 2010// TI - A comprehensive catalogue of somatic mutations from a human cancer genome JO - Nature VL - 463 UR - https://doi.org/10.1038/nature08658 DO - 10.1038/nature08658 ID - Pleasance2010 ER - TY - JOUR AU - Grosenbaugh, D. A. AU - Leard, A. T. AU - Bergman, P. J. AU - Klein, M. K. AU - Meleo, K. AU - Susaneck, S. PY - 2011 DA - 2011// TI - Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor JO - Am J Vet Res VL - 72 UR - https://doi.org/10.2460/ajvr.72.12.1631 DO - 10.2460/ajvr.72.12.1631 ID - Grosenbaugh2011 ER - TY - JOUR AU - Kamb, A. PY - 2005 DA - 2005// TI - What’s wrong with our cancer models? JO - Nat Rev Drug Discov VL - 4 UR - https://doi.org/10.1038/nrd1635 DO - 10.1038/nrd1635 ID - Kamb2005 ER - TY - JOUR AU - Kamb, A. AU - Kamb, A. AU - Wee, S. AU - Wee, S. AU - Lengauer, C. AU - Lengauer, C. PY - 2007 DA - 2007// TI - Why is cancer drug discovery so difficult? JO - Nat Rev Drug Discov VL - 6 UR - https://doi.org/10.1038/nrd2155 DO - 10.1038/nrd2155 ID - Kamb2007 ER - TY - JOUR AU - Paoloni, M. C. AU - Khanna, C. PY - 2007 DA - 2007// TI - Comparative oncology today JO - Vet Clinics N Am-Small Anim Pract VL - 37 UR - https://doi.org/10.1016/j.cvsm.2007.08.003 DO - 10.1016/j.cvsm.2007.08.003 ID - Paoloni2007 ER - TY - JOUR AU - Riccardo, F. AU - Aurisicchio, L. AU - Impellizeri, J. A. AU - Cavallo, F. PY - 2014 DA - 2014// TI - The importance of comparative oncology in translational medicine JO - Cancer Immunol Immunother VL - 64 UR - https://doi.org/10.1007/s00262-014-1645-5 DO - 10.1007/s00262-014-1645-5 ID - Riccardo2014 ER - TY - JOUR AU - Lequarré, A. S. AU - Andersson, L. AU - André, C. AU - Fredholm, M. AU - Hitte, C. AU - Leeb, T. PY - 2011 DA - 2011// TI - LUPA: a European initiative taking advantage of the canine genome architecture for unravelling complex disorders in both human and dogs JO - Vet J VL - 189 UR - https://doi.org/10.1016/j.tvjl.2011.06.013 DO - 10.1016/j.tvjl.2011.06.013 ID - Lequarré2011 ER - TY - JOUR AU - Lollini, P. -. L. AU - Cavallo, F. AU - Nanni, P. AU - Forni, G. PY - 2006 DA - 2006// TI - Vaccines for tumour prevention JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1815 DO - 10.1038/nrc1815 ID - Lollini2006 ER - TY - JOUR AU - Cavallo, F. AU - Calogero, R. A. AU - Forni, G. PY - 2007 DA - 2007// TI - Are oncoantigens suitable targets for anti-tumour therapy? JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2208 DO - 10.1038/nrc2208 ID - Cavallo2007 ER - TY - JOUR AU - Dunn, G. P. AU - Old, L. J. AU - Schreiber, R. D. PY - 2004 DA - 2004// TI - The immunobiology of cancer immunosurveillance and immunoediting JO - Immunity VL - 21 UR - https://doi.org/10.1016/j.immuni.2004.07.017 DO - 10.1016/j.immuni.2004.07.017 ID - Dunn2004 ER - TY - JOUR AU - Cavallo, F. AU - Giovanni, C. AU - Nanni, P. AU - Forni, G. AU - Lollini, P. L. PY - 2011 DA - 2011// TI - The immune hallmarks of cancer JO - Cancer Immunol Immunother VL - 2011 UR - https://doi.org/10.1007/s00262-010-0968-0 DO - 10.1007/s00262-010-0968-0 ID - Cavallo2011 ER - TY - JOUR AU - Iezzi, M. AU - Quaglino, E. AU - Amici, A. AU - Lollini, P. L. AU - Forni, G. AU - Cavallo, F. PY - 2012 DA - 2012// TI - DNA vaccination against oncoantigens: a promise JO - Oncoimmunology VL - 1 UR - https://doi.org/10.4161/onci.19127 DO - 10.4161/onci.19127 ID - Iezzi2012 ER - TY - JOUR AU - Cheever, M. A. AU - Allison, J. P. AU - Ferris, A. S. AU - Finn, O. J. AU - Hastings, B. M. AU - Hecht, T. T. PY - 2009 DA - 2009// TI - The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0737 DO - 10.1158/1078-0432.CCR-09-0737 ID - Cheever2009 ER - TY - JOUR AU - Stallcup, W. B. PY - 2002 DA - 2002// TI - The NG2 proteoglycan: past insights and future prospects JO - J Neurocytol VL - 31 UR - https://doi.org/10.1023/A:1025731428581 DO - 10.1023/A:1025731428581 ID - Stallcup2002 ER - TY - JOUR AU - Campoli, M. AU - Ferrone, S. AU - Wang, X. PY - 2010 DA - 2010// TI - Functional and clinical relevance of chondroitin sulfate proteoglycan 4 JO - Adv Cancer Res VL - 109 UR - https://doi.org/10.1016/B978-0-12-380890-5.00003-X DO - 10.1016/B978-0-12-380890-5.00003-X ID - Campoli2010 ER - TY - JOUR AU - Pluschke, G. AU - Vanek, M. AU - Evans, A. AU - Dittmar, T. AU - Schmid, P. AU - Itin, P. PY - 1996 DA - 1996// TI - Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan JO - Proc Natl Acad Sci USA VL - 93 UR - https://doi.org/10.1073/pnas.93.18.9710 DO - 10.1073/pnas.93.18.9710 ID - Pluschke1996 ER - TY - JOUR AU - Nishiyama, A. AU - Dahlin, K. J. AU - Prince, J. T. AU - Johnstone, S. R. AU - Stallcup, W. B. PY - 1991 DA - 1991// TI - The primary structure of NG2, a novel membrane-spanning proteoglycan JO - J Cell Biol VL - 114 UR - https://doi.org/10.1083/jcb.114.2.359 DO - 10.1083/jcb.114.2.359 ID - Nishiyama1991 ER - TY - JOUR AU - Campoli, M. R. AU - Chang, C. C. AU - Kageshita, T. AU - Wang, X. AU - McCarthy, J. B. AU - Ferrone, S. PY - 2004 DA - 2004// TI - Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance JO - Crit Rev Immunol VL - 24 UR - https://doi.org/10.1615/CritRevImmunol.v24.i4.40 DO - 10.1615/CritRevImmunol.v24.i4.40 ID - Campoli2004 ER - TY - JOUR AU - Stallcup, W. B. AU - Dahlin-Huppe, K. PY - 2001 DA - 2001// TI - Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization JO - J Cell Sci VL - 114 ID - Stallcup2001 ER - TY - JOUR AU - Burg, M. A. AU - Tillet, E. AU - Timpl, R. AU - Stallcup, W. B. PY - 1996 DA - 1996// TI - Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.42.26110 DO - 10.1074/jbc.271.42.26110 ID - Burg1996 ER - TY - JOUR AU - Cattaruzza, S. AU - Nicolosi, P. A. AU - Braghetta, P. AU - Pazzaglia, L. AU - Benassi, M. S. AU - Picci, P. PY - 2013 DA - 2013// TI - NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion JO - J Mol Cell Biol VL - 5 UR - https://doi.org/10.1093/jmcb/mjt010 DO - 10.1093/jmcb/mjt010 ID - Cattaruzza2013 ER - TY - JOUR AU - Cooney, C. A. AU - Jousheghany, F. AU - Yao-Borengasser, A. AU - Phanavanh, B. AU - Gomes, T. AU - Kieber-Emmons, A. M. PY - 2011 DA - 2011// TI - Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr2895 DO - 10.1186/bcr2895 ID - Cooney2011 ER - TY - JOUR AU - Fukushi, J. -. I. AU - Makagiansar, I. T. AU - Stallcup, W. B. PY - 2004 DA - 2004// TI - NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin JO - Mol Biol Cell VL - 15 UR - https://doi.org/10.1091/mbc.E04-03-0236 DO - 10.1091/mbc.E04-03-0236 ID - Fukushi2004 ER - TY - JOUR AU - Nishiyama, A. AU - Lin, X. H. AU - Stallcup, W. B. PY - 1995 DA - 1995// TI - Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis JO - Mol Biol Cell VL - 6 UR - https://doi.org/10.1091/mbc.6.12.1819 DO - 10.1091/mbc.6.12.1819 ID - Nishiyama1995 ER - TY - JOUR AU - Asher, R. A. AU - Morgenstern, D. A. AU - Properzi, F. AU - Nishiyama, A. AU - Levine, J. M. AU - Fawcett, J. W. PY - 2005 DA - 2005// TI - Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro JO - Mol Cell Neurosci VL - 29 UR - https://doi.org/10.1016/j.mcn.2005.02.001 DO - 10.1016/j.mcn.2005.02.001 ID - Asher2005 ER - TY - JOUR AU - Keleg, S. AU - Titov, A. AU - Heller, A. AU - Giese, T. AU - Tjaden, C. AU - Ahmad, S. S. PY - 2014 DA - 2014// TI - Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0100178 DO - 10.1371/journal.pone.0100178 ID - Keleg2014 ER - TY - JOUR AU - Wen, Y. AU - Makagiansar, I. T. AU - Fukushi, J. I. AU - Liu, F. T. AU - Fukuda, M. N. AU - Stallcup, W. B. PY - 2006 DA - 2006// TI - Molecular basis of interaction between NG2 proteoglycan and galectin-3 JO - J Cell Biochem VL - 98 UR - https://doi.org/10.1002/jcb.20768 DO - 10.1002/jcb.20768 ID - Wen2006 ER - TY - JOUR AU - Stegmüller, J. AU - Schneider, S. AU - Hellwig, A. AU - Garwood, J. AU - Trotter, J. PY - 2002 DA - 2002// TI - AN2, the mouse homologue of NG2, is a surface antigen on glial precursor cells implicated in control of cell migration JO - J Neurocytol VL - 31 UR - https://doi.org/10.1023/A:1025743731306 DO - 10.1023/A:1025743731306 ID - Stegmüller2002 ER - TY - JOUR AU - Makagiansar, I. T. AU - Williams, S. AU - Mustelin, T. AU - Stallcup, W. B. PY - 2007 DA - 2007// TI - Differential phosphorylation of NG2 proteoglycan by ERK and PKC?? helps balance cell proliferation and migration JO - J Cell Biol VL - 178 UR - https://doi.org/10.1083/jcb.200612084 DO - 10.1083/jcb.200612084 ID - Makagiansar2007 ER - TY - JOUR AU - Fang, X. AU - Burg, M. A. AU - Barritt, D. AU - Dahlin-Huppe, K. PY - 1999 DA - 1999// TI - Nishiyama a, Stallcup WB. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration JO - Mol Biol Cell VL - 10 UR - https://doi.org/10.1091/mbc.10.10.3373 DO - 10.1091/mbc.10.10.3373 ID - Fang1999 ER - TY - JOUR AU - Couchman, J. R. PY - 2010 DA - 2010// TI - Transmembrane signaling proteoglycans JO - Annu Rev Cell Dev Biol VL - 26 UR - https://doi.org/10.1146/annurev-cellbio-100109-104126 DO - 10.1146/annurev-cellbio-100109-104126 ID - Couchman2010 ER - TY - JOUR AU - Price, M. A. AU - Colvin Wanshura, L. E. AU - Yang, J. AU - Carlson, J. AU - Xiang, B. AU - Li, G. PY - 2011 DA - 2011// TI - CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma JO - Pigment Cell Melanoma Res VL - 24 UR - https://doi.org/10.1111/j.1755-148X.2011.00929.x DO - 10.1111/j.1755-148X.2011.00929.x ID - Price2011 ER - TY - JOUR AU - Tillet, E. AU - Ruggiero, F. AU - Nishiyama, A. AU - Stallcup, W. B. PY - 1997 DA - 1997// TI - The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.16.10769 DO - 10.1074/jbc.272.16.10769 ID - Tillet1997 ER - TY - JOUR AU - Chatterjee, N. AU - Stegmüller, J. AU - Schätzle, P. AU - Karram, K. AU - Koroll, M. AU - Werner, H. B. PY - 2008 DA - 2008// TI - Interaction of syntenin-1 and the NG2 proteoglycan in migratory oligodendrocyte precursor cells JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M706074200 DO - 10.1074/jbc.M706074200 ID - Chatterjee2008 ER - TY - JOUR AU - Midwood, K. S. AU - Salter, D. M. PY - 1998 DA - 1998// TI - Expression of NG2/human melanoma proteoglycan in human adult articular chondrocytes JO - Osteoarthr Cartil VL - 6 UR - https://doi.org/10.1053/joca.1998.0128 DO - 10.1053/joca.1998.0128 ID - Midwood1998 ER - TY - JOUR AU - Petrini, S. AU - Tessa, A. AU - Carrozzo, R. AU - Verardo, M. AU - Pierini, R. AU - Rizza, T. PY - 2003 DA - 2003// TI - Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers: abnormal expression in merosin-negative and Duchenne muscular dystrophies JO - Mol Cell Neurosci VL - 23 UR - https://doi.org/10.1016/S1044-7431(03)00033-2 DO - 10.1016/S1044-7431(03)00033-2 ID - Petrini2003 ER - TY - JOUR AU - Kozanoglu, I. AU - Boga, C. AU - Ozdogu, H. AU - Sozer, O. AU - Maytalman, E. AU - Yazici, A. C. PY - 2009 DA - 2009// TI - Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification JO - Cytotherapy VL - 11 UR - https://doi.org/10.1080/14653240902923153 DO - 10.1080/14653240902923153 ID - Kozanoglu2009 ER - TY - JOUR AU - Nicolosi, P. A. AU - Dallatomasina, A. AU - Perris, R. PY - 2015 DA - 2015// TI - Theranostic impact of NG2/CSPG4 proteoglycan in cancer JO - Theranostics VL - 5 UR - https://doi.org/10.7150/thno.10824 DO - 10.7150/thno.10824 ID - Nicolosi2015 ER - TY - JOUR AU - Schlingemann, R. O. AU - Rietveld, F. J. AU - Waal, R. M. AU - Ferrone, S. AU - Ruiter, D. J. PY - 1990 DA - 1990// TI - Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds JO - Am J Pathol VL - 136 ID - Schlingemann1990 ER - TY - JOUR AU - Huang, F. J. AU - You, W. K. AU - Bonaldo, P. AU - Seyfried, T. N. AU - Pasquale, E. B. AU - Stallcup, W. B. PY - 2010 DA - 2010// TI - Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse JO - Dev Biol VL - 344 UR - https://doi.org/10.1016/j.ydbio.2010.06.023 DO - 10.1016/j.ydbio.2010.06.023 ID - Huang2010 ER - TY - JOUR AU - Hsu, N. C. AU - Nien, P. Y. AU - Yokoyama, K. K. AU - Chu, P. Y. AU - Hou, M. F. PY - 2013 DA - 2013// TI - High chondroitin sulfate proteoglycan 4 expression correlates with poor outcome in patients with breast cancer JO - Biochem Biophys Res Commun. VL - 441 UR - https://doi.org/10.1016/j.bbrc.2013.10.093 DO - 10.1016/j.bbrc.2013.10.093 ID - Hsu2013 ER - TY - JOUR AU - Rivera, Z. AU - Ferrone, S. AU - Wang, X. AU - Jube, S. AU - Yang, H. AU - Pass, H. I. PY - 2012 DA - 2012// TI - CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0628 DO - 10.1158/1078-0432.CCR-12-0628 ID - Rivera2012 ER - TY - JOUR AU - Wang, X. X. AU - Wang, Y. AU - Yu, L. AU - Sakakura, K. AU - Visus, C. AU - Schwab, J. H. PY - 2010 DA - 2010// TI - CSPG4 in cancer: multiple roles JO - Curr Mol Med VL - 10 UR - https://doi.org/10.2174/156652410791316977 DO - 10.2174/156652410791316977 ID - Wang2010 ER - TY - JOUR AU - Petrovici, K. AU - Graf, M. AU - Hecht, K. AU - Reif, S. AU - Pfister, K. AU - Schmetzer, H. PY - 2010 DA - 2010// TI - Use of NG2 (7.1) in AML as a tumor marker and its association with a poor prognosis JO - Cancer Genom Proteom VL - 7 ID - Petrovici2010 ER - TY - JOUR AU - Wilson, B. S. AU - Ruberto, G. AU - Ferrone, S. PY - 1983 DA - 1983// TI - Immunochemical characterization of a human high molecular weight melanoma associated antigen identified with monoclonal antibodies JO - Cancer Immunol Immunother VL - 14 UR - https://doi.org/10.1007/BF00205360 DO - 10.1007/BF00205360 ID - Wilson1983 ER - TY - JOUR AU - Giacomini, P. AU - Veglia, F. AU - Rehle, T. AU - Natali, P. G. AU - Fei, P. C. AU - Ferrone, S. PY - 1984 DA - 1984// TI - Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma JO - Cancer Res VL - 44 ID - Giacomini1984 ER - TY - JOUR AU - Andres, J. L. AU - DeFalcis, D. AU - Noda, M. AU - Massague, J. PY - 1992 DA - 1992// TI - Binding of two growth factor families to separate domains of the proteoglycan betaglycan JO - J Biol Chem VL - 267 ID - Andres1992 ER - TY - JOUR AU - Wang, J. AU - Svendsen, A. AU - Kmiecik, J. AU - Immervol, H. AU - Skaftnesmo, K. O. AU - Planagum, J. PY - 2011 DA - 2011// TI - Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0023062 DO - 10.1371/journal.pone.0023062 ID - Wang2011 ER - TY - JOUR AU - Yang, J. AU - Price, M. A. AU - Neudauer, C. L. AU - Wilson, C. AU - Ferrone, S. AU - Xia, H. PY - 2004 DA - 2004// TI - Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms JO - J Cell Biol VL - 165 UR - https://doi.org/10.1083/jcb.200403174 DO - 10.1083/jcb.200403174 ID - Yang2004 ER - TY - JOUR AU - Iida, J. AU - Meijne, A. M. AU - Spiro, R. C. AU - Roos, E. AU - Furcht, L. T. AU - McCarthy, J. B. PY - 1995 DA - 1995// TI - Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin JO - Cancer Res VL - 55 ID - Iida1995 ER - TY - JOUR AU - Joo, N. E. AU - Watanabe, T. AU - Chen, C. AU - Chekenya, M. AU - Stallcup, W. B. AU - Kapila, Y. L. PY - 2008 DA - 2008// TI - NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation JO - Cell Death Differ VL - 15 UR - https://doi.org/10.1038/cdd.2008.22 DO - 10.1038/cdd.2008.22 ID - Joo2008 ER - TY - JOUR AU - Parsons, J. T. AU - Martin, K. H. AU - Slack, J. K. AU - Taylor, J. M. AU - Weed, S. A. PY - 2000 DA - 2000// TI - Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement JO - Oncogene VL - 19 UR - https://doi.org/10.1038/sj.onc.1203877 DO - 10.1038/sj.onc.1203877 ID - Parsons2000 ER - TY - JOUR AU - Eisenmann, K. M. AU - McCarthy, J. B. AU - Simpson, M. A. AU - Keely, P. J. AU - Guan, J. L. AU - Tachibana, K. PY - 1999 DA - 1999// TI - Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas JO - Nat Cell Biol. VL - 1 UR - https://doi.org/10.1038/70302 DO - 10.1038/70302 ID - Eisenmann1999 ER - TY - JOUR AU - Cabodi, S. AU - Tinnirello, A. AU - Stefano, P. AU - Bisarò, B. AU - Ambrosino, E. AU - Castellano, I. PY - 2006 DA - 2006// TI - p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-2909 DO - 10.1158/0008-5472.CAN-05-2909 ID - Cabodi2006 ER - TY - JOUR AU - Chekenya, M. AU - Krakstad, C. AU - Svendsen, A. AU - Netland, I. AU - Staalesen, V. AU - Tysnes, B. B. PY - 2008 DA - 2008// TI - The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signalling JO - Oncogene VL - 4157 UR - https://doi.org/10.1038/onc.2008.157 DO - 10.1038/onc.2008.157 ID - Chekenya2008 ER - TY - JOUR AU - Svendsen, A. AU - Verhoeff, J. J. C. AU - Immervoll, H. AU - Brøgger, J. C. AU - Kmiecik, J. AU - Poli, A. PY - 2011 DA - 2011// TI - Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma JO - Acta Neuropathol VL - 122 UR - https://doi.org/10.1007/s00401-011-0867-2 DO - 10.1007/s00401-011-0867-2 ID - Svendsen2011 ER - TY - JOUR AU - Wang, X. AU - Osada, T. AU - Wang, Y. AU - Yu, L. AU - Sakakura, K. AU - Katayama, A. PY - 2010 DA - 2010// TI - CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq343 DO - 10.1093/jnci/djq343 ID - Wang2010 ER - TY - JOUR AU - Lazar, I. AU - Clement, E. AU - Ducoux-Petit, M. AU - Denat, L. AU - Soldan, V. AU - Dauvillier, S. PY - 2015 DA - 2015// TI - Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines JO - Pigment Cell Melanoma Res VL - 28 UR - https://doi.org/10.1111/pcmr.12380 DO - 10.1111/pcmr.12380 ID - Lazar2015 ER - TY - JOUR AU - Visvader, J. E. AU - Lindeman, G. J. PY - 2008 DA - 2008// TI - Cancer stem cells in solid tumours: accumulating evidence and unresolved questions JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2499 DO - 10.1038/nrc2499 ID - Visvader2008 ER - TY - JOUR AU - Hood, J. L. AU - San Roman, S. AU - Wickline, S. A. PY - 2011 DA - 2011// TI - Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-4455 DO - 10.1158/0008-5472.CAN-10-4455 ID - Hood2011 ER - TY - JOUR AU - Yu, S. AU - Cao, H. AU - Shen, B. AU - Feng, J. PY - 2015 DA - 2015// TI - Tumor-derived exosomes in cancer progression and treatment failure JO - Oncotarget VL - 6 ID - Yu2015 ER - TY - JOUR AU - Paoloni, M. AU - Khanna, C. PY - 2008 DA - 2008// TI - Translation of new cancer treatments from pet dogs to humans JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2273 DO - 10.1038/nrc2273 ID - Paoloni2008 ER - TY - JOUR AU - Tamburini, B. A. AU - Trapp, S. AU - Phang, T. L. AU - Schappa, J. T. AU - Hunter, L. E. AU - Modiano, J. F. PY - 2009 DA - 2009// TI - Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0005549 DO - 10.1371/journal.pone.0005549 ID - Tamburini2009 ER - TY - JOUR AU - Marconato, L. AU - Martini, V. AU - Aresu, L. AU - Sampaolo, M. AU - Valentini, F. AU - Rinaldi, V. PY - 2013 DA - 2013// TI - Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: prognostic significance and proposal of a cut-off value JO - Vet J VL - 197 UR - https://doi.org/10.1016/j.tvjl.2013.05.003 DO - 10.1016/j.tvjl.2013.05.003 ID - Marconato2013 ER - TY - JOUR AU - Rivera, P. AU - Euler, H. PY - 2010 DA - 2010// TI - Molecular biological aspects on canine and human mammary tumors JO - Vet Pathol VL - 2011 ID - Rivera2010 ER - TY - JOUR AU - Bergman, P. J. PY - 2007 DA - 2007// TI - Canine oral melanoma JO - Clin Tech Small Anim Pract. VL - 22 UR - https://doi.org/10.1053/j.ctsap.2007.03.004 DO - 10.1053/j.ctsap.2007.03.004 ID - Bergman2007 ER - TY - JOUR AU - Maniscalco, L. AU - Iussich, S. AU - Morello, E. AU - Martano, M. AU - Biolatti, B. AU - Riondato, F. PY - 2013 DA - 2013// TI - PDGFs and PDGFRs in canine osteosarcoma: new targets for innovative therapeutic strategies in comparative oncology JO - Vet J. VL - 195 UR - https://doi.org/10.1016/j.tvjl.2012.05.003 DO - 10.1016/j.tvjl.2012.05.003 ID - Maniscalco2013 ER - TY - JOUR AU - Improta, G. AU - Leone, I. AU - Donia, M. AU - Gieri, S. AU - Pelosi, G. AU - Fraggetta, F. PY - 2015 DA - 2015// TI - New developments in the management of advanced melanoma-role of pembrolizumab JO - OncoTargets Ther VL - 8 UR - https://doi.org/10.2147/OTT.S72823 DO - 10.2147/OTT.S72823 ID - Improta2015 ER - TY - JOUR AU - Proulx, D. R. AU - Ruslander, D. M. AU - Dodge, R. K. AU - Hauck, M. L. AU - Williams, L. E. AU - Horn, B. PY - 2003 DA - 2003// TI - A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation JO - Vet Radiol Ultrasound VL - 44 UR - https://doi.org/10.1111/j.1740-8261.2003.tb00468.x DO - 10.1111/j.1740-8261.2003.tb00468.x ID - Proulx2003 ER - TY - JOUR AU - Murphy, S. AU - Hayes, A. M. AU - Blackwood, L. AU - Maglennon, G. AU - Pattinson, H. AU - Sparkes, A. H. PY - 2005 DA - 2005// TI - Oral malignant melanoma-the effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy JO - Vet Comp Oncol VL - 3 UR - https://doi.org/10.1111/j.1476-5810.2005.00082.x DO - 10.1111/j.1476-5810.2005.00082.x ID - Murphy2005 ER - TY - JOUR AU - Mayayo, S. L. AU - Prestigio, S. AU - Maniscalco, L. AU - Rosa, G. AU - Aricò, A. AU - Maria, R. PY - 2011 DA - 2011// TI - Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma JO - Vet J. VL - 190 UR - https://doi.org/10.1016/j.tvjl.2011.02.020 DO - 10.1016/j.tvjl.2011.02.020 ID - Mayayo2011 ER - TY - JOUR AU - Morello, E. AU - Martano, M. AU - Buracco, P. PY - 2011 DA - 2011// TI - Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma JO - Vet J VL - 189 UR - https://doi.org/10.1016/j.tvjl.2010.08.014 DO - 10.1016/j.tvjl.2010.08.014 ID - Morello2011 ER - TY - JOUR AU - Rosenberg, S. A. AU - Packard, B. S. AU - Aebersold, P. M. AU - Solomon, D. AU - Topalian, S. L. AU - Toy, S. T. PY - 1988 DA - 1988// TI - Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report JO - N Engl J Med VL - 319 UR - https://doi.org/10.1056/NEJM198812223192527 DO - 10.1056/NEJM198812223192527 ID - Rosenberg1988 ER - TY - JOUR AU - Dudley, M. E. AU - Wunderlich, J. AU - Nishimura, M. I. AU - Yu, D. AU - Yang, J. C. AU - Topalian, S. L. PY - 2001 DA - 2001// TI - Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma JO - J Immunother VL - 24 UR - https://doi.org/10.1097/00002371-200107000-00012 DO - 10.1097/00002371-200107000-00012 ID - Dudley2001 ER - TY - JOUR AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Yang, J. C. AU - Hwu, P. AU - Schwartzentruber, D. J. AU - Topalian, S. L. PY - 2002 DA - 2002// TI - A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma JO - J Immunother VL - 25 UR - https://doi.org/10.1097/00002371-200205000-00007 DO - 10.1097/00002371-200205000-00007 ID - Dudley2002 ER - TY - JOUR AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Yang, J. C. AU - Sherry, R. M. AU - Topalian, S. L. AU - Restifo, N. P. PY - 2005 DA - 2005// TI - Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.00.240 DO - 10.1200/JCO.2005.00.240 ID - Dudley2005 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. AU - Yang, J. C. AU - Morgan, R. A. AU - Dudley, M. E. PY - 2008 DA - 2008// TI - Adoptive cell transfer: a clinical path to effective cancer immunotherapy JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2355 DO - 10.1038/nrc2355 ID - Rosenberg2008 ER - TY - JOUR AU - Morgan, R. A. AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Hughes, M. S. AU - Yang, J. C. AU - Sherry, R. M. PY - 2006 DA - 2006// TI - Cancer regression in patients after transfer of genetically engineered lymphocytes JO - Science VL - 314 UR - https://doi.org/10.1126/science.1129003 DO - 10.1126/science.1129003 ID - Morgan2006 ER - TY - JOUR AU - Grupp, S. A. AU - Kalos, M. AU - Barrett, D. AU - Aplenc, R. AU - Porter, D. L. AU - Rheingold, S. R. PY - 2013 DA - 2013// TI - Chimeric antigen receptor-modified T cells for acute lymphoid leukemia JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1215134 DO - 10.1056/NEJMoa1215134 ID - Grupp2013 ER - TY - JOUR AU - Anurathapan, U. AU - Chan, R. C. AU - Hindi, H. F. AU - Mucharla, R. AU - Bajgain, P. AU - Hayes, B. C. PY - 2014 DA - 2014// TI - Kinetics of tumor destruction by chimeric antigen receptor-modified T cells JO - Mol Ther VL - 22 UR - https://doi.org/10.1038/mt.2013.262 DO - 10.1038/mt.2013.262 ID - Anurathapan2014 ER - TY - JOUR AU - Gill, S. AU - Maus, M. V. AU - Porter, D. L. PY - 2015 DA - 2015// TI - Chimeric antigen receptor T cell therapy: 25 years in the making JO - Blood Rev VL - 30 UR - https://doi.org/10.1016/j.blre.2015.10.003 DO - 10.1016/j.blre.2015.10.003 ID - Gill2015 ER - TY - JOUR AU - Geldres, C. AU - Savoldo, B. AU - Hoyos, V. AU - Caruana, I. AU - Zhang, M. AU - Yvon, E. PY - 2014 DA - 2014// TI - T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2218 DO - 10.1158/1078-0432.CCR-13-2218 ID - Geldres2014 ER - TY - JOUR AU - Burns, W. R. AU - Zhao, Y. AU - Frankel, T. L. AU - Hinrichs, C. S. AU - Zheng, Z. AU - Xu, H. PY - 2010 DA - 2010// TI - A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-2824 DO - 10.1158/0008-5472.CAN-09-2824 ID - Burns2010 ER - TY - JOUR AU - Beard, R. E. AU - Zheng, Z. AU - Lagisetty, K. H. AU - Burns, W. R. AU - Tran, E. AU - Hewitt, S. M. PY - 2014 DA - 2014// TI - Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells JO - J Immunother Cancer VL - 2 UR - https://doi.org/10.1186/2051-1426-2-25 DO - 10.1186/2051-1426-2-25 ID - Beard2014 ER - TY - JOUR AU - Wang, Y. AU - Geldres, C. AU - Ferrone, S. AU - Dotti, G. PY - 2015 DA - 2015// TI - Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors JO - Expert Opin Ther Targets. VL - 19 UR - https://doi.org/10.1517/14728222.2015.1068759 DO - 10.1517/14728222.2015.1068759 ID - Wang2015 ER - TY - JOUR AU - Schmidt, P. AU - Kopecky, C. AU - Hombach, A. AU - Zigrino, P. AU - Mauch, C. AU - Abken, H. PY - 2011 DA - 2011// TI - Eradication of melanomas by targeted elimination of a minor subset of tumor cells JO - Proc Natl Acad Sci USA. VL - 108 UR - https://doi.org/10.1073/pnas.1009069108 DO - 10.1073/pnas.1009069108 ID - Schmidt2011 ER - TY - JOUR AU - Uslu, U. AU - Schuler, G. AU - Dörrie, J. AU - Schaft, N. PY - 2016 DA - 2016// TI - Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma JO - Exp Dermatol VL - 25 UR - https://doi.org/10.1111/exd.13095 DO - 10.1111/exd.13095 ID - Uslu2016 ER - TY - JOUR AU - Erfurt, C. AU - Sun, Z. AU - Haendle, I. AU - Heirman, C. AU - Thielemans, K. AU - Der, B. r. u. g. g. e. n. V. PY - 2007 DA - 2007// TI - Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity JO - J Immunol. VL - 178 UR - https://doi.org/10.4049/jimmunol.178.12.7703 DO - 10.4049/jimmunol.178.12.7703 ID - Erfurt2007 ER - TY - JOUR AU - Erfurt, C. AU - Müller, E. AU - Emmerling, S. AU - Klotz, C. AU - Hertl, M. AU - Schuler, G. PY - 2009 DA - 2009// TI - Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24235 DO - 10.1002/ijc.24235 ID - Erfurt2009 ER - TY - JOUR AU - Poggi, A. AU - Musso, A. AU - Dapino, I. AU - Zocchi, M. R. PY - 2014 DA - 2014// TI - Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells JO - Immunol Lett VL - 159 UR - https://doi.org/10.1016/j.imlet.2014.03.001 DO - 10.1016/j.imlet.2014.03.001 ID - Poggi2014 ER - TY - JOUR AU - Dunn, G. P. AU - Bruce, A. T. AU - Ikeda, H. AU - Old, L. J. AU - Schreiber, R. D. PY - 2002 DA - 2002// TI - Cancer immunoediting: from immunosurveillance to tumor escape JO - Nat Immunol VL - 3 UR - https://doi.org/10.1038/ni1102-991 DO - 10.1038/ni1102-991 ID - Dunn2002 ER - TY - JOUR AU - Poli, A. AU - Wang, J. AU - Domingues, O. AU - Planagumà, J. AU - Yan, T. AU - Rygh, C. B. PY - 2013 DA - 2013// TI - Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival JO - Oncotarget. VL - 4 UR - https://doi.org/10.18632/oncotarget.1291 DO - 10.18632/oncotarget.1291 ID - Poli2013 ER - TY - STD TI - Piras LA, Riccardo F, Iussich S, Maniscalco L, Gattino F, Martano M, et al. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination. Vet Comp Oncol. 2016. ID - ref96 ER - TY - JOUR AU - Tordsson, J. M. AU - Ohlsson, L. G. AU - Abrahmsén, L. B. AU - Karlström, P. J. AU - Lando, P. A. AU - Brodin, T. N. PY - 2000 DA - 2000// TI - Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma JO - Cancer Immunol Immunother. VL - 48 UR - https://doi.org/10.1007/s002620050018 DO - 10.1007/s002620050018 ID - Tordsson2000 ER - TY - JOUR AU - Bruyn, M. AU - Rybczynska, A. A. AU - Wei, Y. AU - Schwenkert, M. AU - Fey, G. H. AU - Dierckx, R. A. PY - 2010 DA - 2010// TI - Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo JO - Mol Cancer VL - 9 UR - https://doi.org/10.1186/1476-4598-9-301 DO - 10.1186/1476-4598-9-301 ID - Bruyn2010 ER - TY - JOUR AU - Bluemel, C. AU - Hausmann, S. AU - Fluhr, P. AU - Sriskandarajah, M. AU - Stallcup, W. B. AU - Baeuerle, P. A. PY - 2010 DA - 2010// TI - Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen JO - Cancer Immunol Immunother VL - 59 UR - https://doi.org/10.1007/s00262-010-0844-y DO - 10.1007/s00262-010-0844-y ID - Bluemel2010 ER - TY - JOUR AU - Torisu-Itakura, H. AU - Schoellhammer, H. F. AU - Sim, M. -. S. AU - Irie, R. F. AU - Hausmann, S. AU - Raum, T. PY - 2011 DA - 2011// TI - Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells JO - J Immunother VL - 34 UR - https://doi.org/10.1097/CJI.0b013e3182307fd8 DO - 10.1097/CJI.0b013e3182307fd8 ID - Torisu-Itakura2011 ER - TY - JOUR AU - Amoury, M. AU - Mladenov, R. AU - Nachreiner, T. AU - Pham, A. T. AU - Hristodorov, D. AU - Fiore, S. PY - 2016 DA - 2016// TI - A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein JO - Int J Cancer VL - 139 UR - https://doi.org/10.1002/ijc.30119 DO - 10.1002/ijc.30119 ID - Amoury2016 ER - TY - JOUR AU - Yu, L. AU - Favoino, E. AU - Wang, Y. AU - Ma, Y. AU - Deng, X. AU - Wang, X. PY - 2011 DA - 2011// TI - The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells JO - Immunol Res VL - 50 UR - https://doi.org/10.1007/s12026-011-8232-z DO - 10.1007/s12026-011-8232-z ID - Yu2011 ER - TY - JOUR AU - Pucciarelli, D. AU - Lengger, N. AU - Takacova, M. AU - Csaderova, L. AU - Bartosova, M. AU - Breiteneder, H. PY - 2015 DA - 2015// TI - Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia JO - Int J Oncol VL - 47 ID - Pucciarelli2015 ER - TY - JOUR AU - Mittelman, A. AU - Chen, Z. J. AU - Kageshita, T. AU - Yang, H. AU - Yamada, M. AU - Baskind, P. PY - 1990 DA - 1990// TI - Active specific immunotherapy in patients with melanoma: a clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies JO - J Clin Invest VL - 86 UR - https://doi.org/10.1172/JCI114952 DO - 10.1172/JCI114952 ID - Mittelman1990 ER - TY - JOUR AU - Mittelman, A. AU - Chen, G. Z. J. AU - Wong, G. Y. AU - Liu, C. AU - Hirai, S. AU - Ferrone, S. PY - 1995 DA - 1995// TI - Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody mk2-23: modulation of the immunogenicity in patients with malignant melanoma JO - Clin Cancer Res VL - 1 ID - Mittelman1995 ER - TY - JOUR AU - Wang, X. AU - Ko, E. C. AU - Peng, L. AU - Gillies, S. D. AU - Ferrone, S. PY - 2005 DA - 2005// TI - Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2 JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-2328 DO - 10.1158/0008-5472.CAN-04-2328 ID - Wang2005 ER - TY - JOUR AU - Riemer, A. B. AU - Hantusch, B. AU - Sponer, B. AU - Kraml, G. AU - Hafner, C. AU - Zielinski, C. C. PY - 2005 DA - 2005// TI - High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells JO - Cancer Immunol Immunother VL - 54 UR - https://doi.org/10.1007/s00262-004-0632-7 DO - 10.1007/s00262-004-0632-7 ID - Riemer2005 ER - TY - JOUR AU - Wagner, S. AU - Hafner, C. AU - Allwardt, D. AU - Jasinska, J. AU - Ferrone, S. AU - Zielinski, C. C. PY - 2005 DA - 2005// TI - Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.2.976 DO - 10.4049/jimmunol.174.2.976 ID - Wagner2005 ER - TY - JOUR AU - Luo, W. AU - Ko, E. AU - Hsu, J. C. AU - Wang, X. AU - Ferrone, S. PY - 2006 DA - 2006// TI - Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects JO - J Immunol VL - 176 UR - https://doi.org/10.4049/jimmunol.176.10.6046 DO - 10.4049/jimmunol.176.10.6046 ID - Luo2006 ER - TY - JOUR AU - Stevenson, F. K. AU - Ottensmeier, C. H. AU - Rice, J. PY - 2010 DA - 2010// TI - DNA vaccines against cancer come of age JO - Curr Opin Immunol VL - 22 UR - https://doi.org/10.1016/j.coi.2010.01.019 DO - 10.1016/j.coi.2010.01.019 ID - Stevenson2010 ER - TY - JOUR AU - Klinman, D. M. AU - Yamshchikov, G. AU - Ishigatsubo, Y. PY - 1997 DA - 1997// TI - Contribution of CpG motifs to the immunogenicity of DNA vaccines JO - J Immunol. VL - 158 ID - Klinman1997 ER - TY - JOUR AU - Bourgeois, C. AU - Rocha, B. AU - Tanchot, C. PY - 2002 DA - 2002// TI - A role for CD40 expression on CD8 + T cells in the generation of CD8+ T cell memory JO - Science VL - 297 UR - https://doi.org/10.1126/science.1072615 DO - 10.1126/science.1072615 ID - Bourgeois2002 ER - TY - JOUR AU - Cavallo, F. AU - Offringa, R. AU - Burg, S. H. AU - Forni, G. AU - Melief, C. J. M. PY - 2006 DA - 2006// TI - Vaccination for treatment and prevention of cancer in animal models JO - Adv Immunol VL - 90 UR - https://doi.org/10.1016/S0065-2776(06)90005-4 DO - 10.1016/S0065-2776(06)90005-4 ID - Cavallo2006 ER - TY - JOUR AU - Quaglino, E. AU - Iezzi, M. AU - Mastini, C. AU - Amici, A. AU - Pericle, F. AU - Carlo, E. PY - 2004 DA - 2004// TI - Electroporated DNA vaccine clears away multifocal mammary carcinomas in Her-2/neu transgenic mice JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2962 DO - 10.1158/0008-5472.CAN-03-2962 ID - Quaglino2004 ER - TY - JOUR AU - Senovilla, L. AU - Vacchelli, E. AU - Garcia, P. AU - Eggermont, A. AU - Fridman, W. H. AU - Galon, J. PY - 2013 DA - 2013// TI - Trial watch: DNA vaccines for cancer therapy JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.23803 DO - 10.4161/onci.23803 ID - Senovilla2013 ER - TY - JOUR AU - Herrada, A. A. AU - Rojas-Colonelli, N. AU - González-Figueroa, P. AU - Roco, J. AU - Oyarce, C. AU - Ligtenberg, M. A. PY - 2012 DA - 2012// TI - Harnessing DNA-induced immune responses for improving cancer vaccines JO - Hum Vaccines Immunother VL - 8 UR - https://doi.org/10.4161/hv.22345 DO - 10.4161/hv.22345 ID - Herrada2012 ER - TY - JOUR AU - Arigoni, M. AU - Barutello, G. AU - Lanzardo, S. AU - Longo, D. AU - Aime, S. AU - Curcio, C. PY - 2012 DA - 2012// TI - A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors JO - Angiogenesis VL - 15 UR - https://doi.org/10.1007/s10456-012-9263-3 DO - 10.1007/s10456-012-9263-3 ID - Arigoni2012 ER - TY - JOUR AU - Aurisicchio, L. AU - Mancini, R. AU - Ciliberto, G. PY - 2013 DA - 2013// TI - Cancer vaccination by electro-gene-transfer JO - Expert Rev Vaccines. VL - 11 ID - Aurisicchio2013 ER - TY - JOUR AU - Cappello, P. AU - Rolla, S. AU - Chiarle, R. AU - Principe, M. AU - Cavallo, F. AU - Perconti, G. PY - 2013 DA - 2013// TI - Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer JO - Gastroenterology VL - 144 UR - https://doi.org/10.1053/j.gastro.2013.01.020 DO - 10.1053/j.gastro.2013.01.020 ID - Cappello2013 ER - TY - STD TI - Marchini C, Kalogris C, Garulli C, Pietrella L, Gabrielli F, Curcio C, et al. Tailoring DNA vaccines: designing strategies against HER2-positive cancers. Front Oncol. 2013;3. ID - ref120 ER - TY - JOUR AU - Riccardo, F. AU - Iussich, S. AU - Maniscalco, L. AU - Mayayo, S. L. AU - Rosa, G. AU - Arigoni, M. PY - 2014 DA - 2014// TI - CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-3042 DO - 10.1158/1078-0432.CCR-13-3042 ID - Riccardo2014 ER - TY - JOUR AU - Yuan, J. AU - Ku, G. Y. AU - Gallardo, H. F. AU - Orlandi, F. AU - Manukian, G. AU - Rasalan, T. S. PY - 2009 DA - 2009// TI - Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma JO - Cancer Immun Arch VL - 9 ID - Yuan2009 ER - TY - JOUR AU - Soong, R. S. AU - Trieu, J. AU - Lee, S. Y. AU - He, L. AU - Tsai, Y. C. AU - Wu, T. C. PY - 2013 DA - 2013// TI - Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53 JO - PLoS One. VL - 8 UR - https://doi.org/10.1371/journal.pone.0056912 DO - 10.1371/journal.pone.0056912 ID - Soong2013 ER - TY - JOUR AU - Cavallo, F. AU - Aurisicchio, L. AU - Mancini, R. AU - Ciliberto, G. PY - 2014 DA - 2014// TI - Xenogene vaccination in the therapy of cancer JO - Expert Opin Biol Ther. VL - 14 UR - https://doi.org/10.1517/14712598.2014.927433 DO - 10.1517/14712598.2014.927433 ID - Cavallo2014 ER - TY - JOUR AU - Alexander, A. N. AU - Huelsmeyer, M. K. AU - Mitzey, A. AU - Dubielzig, R. R. AU - Kurzman, I. D. AU - MacEwen, E. G. PY - 2006 DA - 2006// TI - Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma JO - Cancer Immunol Immunother VL - 55 UR - https://doi.org/10.1007/s00262-005-0025-6 DO - 10.1007/s00262-005-0025-6 ID - Alexander2006 ER - TY - JOUR AU - Bergman, P. J. AU - Camps-Palau, M. A. AU - McKnight, J. A. AU - Leibman, N. F. AU - Craft, D. M. AU - Leung, C. PY - 2006 DA - 2006// TI - Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center JO - Vaccine. VL - 24 UR - https://doi.org/10.1016/j.vaccine.2005.08.027 DO - 10.1016/j.vaccine.2005.08.027 ID - Bergman2006 ER - TY - JOUR AU - Ottnod, J. M. AU - Smedley, R. C. AU - Walshaw, R. AU - Hauptman, J. G. AU - Kiupel, M. AU - Obradovich, J. E. PY - 2013 DA - 2013// TI - A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma JO - Vet Comp Oncol. VL - 11 UR - https://doi.org/10.1111/vco.12057 DO - 10.1111/vco.12057 ID - Ottnod2013 ER - TY - JOUR AU - Quaglino, E. AU - Mastini, C. AU - Amici, A. AU - Marchini, C. AU - lezzi, M. AU - Lanzardo, S. PY - 2010 DA - 2010// TI - A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-2548 DO - 10.1158/0008-5472.CAN-09-2548 ID - Quaglino2010 ER -